London · Delayed Price · Currency is GBP · Price in GBX GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of GBP 77.40 billion. The enterprise value is 92.11 billion.
| Market Cap | 77.40B |
| Enterprise Value | 92.11B |
Important Dates
The last earnings date was Tuesday, July 28, 2026.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | Aug 13, 2026 |
Share Statistics
GSK plc has 4.01 billion shares outstanding. The number of shares has decreased by -1.36% in one year.
| Current Share Class | 4.01B |
| Shares Outstanding | 4.01B |
| Shares Change (YoY) | -1.36% |
| Shares Change (QoQ) | -0.29% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 86.77% |
| Float | 3.86B |
Valuation Ratios
The trailing PE ratio is 16.39 and the forward PE ratio is 10.33. GSK plc's PEG ratio is 1.60.
| PE Ratio | 16.39 |
| Forward PE | 10.33 |
| PS Ratio | 2.33 |
| PB Ratio | 4.51 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.22 |
| P/OCF Ratio | 9.29 |
| PEG Ratio | 1.60 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.36, with an EV/FCF ratio of 13.35.
| EV / Earnings | 19.11 |
| EV / Sales | 2.77 |
| EV / EBITDA | 8.36 |
| EV / EBIT | 9.51 |
| EV / FCF | 13.35 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.06.
| Current Ratio | 0.82 |
| Quick Ratio | 0.52 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | 1.66 |
| Debt / FCF | 2.65 |
| Interest Coverage | 14.65 |
Financial Efficiency
Return on equity (ROE) is 33.38% and return on invested capital (ROIC) is 26.38%.
| Return on Equity (ROE) | 33.38% |
| Return on Assets (ROA) | 10.01% |
| Return on Invested Capital (ROIC) | 26.38% |
| Return on Capital Employed (ROCE) | 24.09% |
| Weighted Average Cost of Capital (WACC) | 5.37% |
| Revenue Per Employee | 496,746 |
| Profits Per Employee | 72,126 |
| Employee Count | 66,841 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.42 |
Taxes
In the past 12 months, GSK plc has paid 641.00 million in taxes.
| Income Tax | 641.00M |
| Effective Tax Rate | 10.86% |
Stock Price Statistics
The stock price has increased by +32.07% in the last 52 weeks. The beta is 0.30, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +32.07% |
| 50-Day Moving Average | 1,939.67 |
| 200-Day Moving Average | 1,930.04 |
| Relative Strength Index (RSI) | 47.72 |
| Average Volume (20 Days) | 8,644,232 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of GBP 33.20 billion and earned 4.82 billion in profits. Earnings per share was 1.18.
| Revenue | 33.20B |
| Gross Profit | 24.40B |
| Operating Income | 9.69B |
| Pretax Income | 5.90B |
| Net Income | 4.82B |
| EBITDA | 10.82B |
| EBIT | 9.69B |
| Earnings Per Share (EPS) | 1.18 |
Balance Sheet
The company has 3.11 billion in cash and 18.29 billion in debt, with a net cash position of -15.19 billion or -3.79 per share.
| Cash & Cash Equivalents | 3.11B |
| Total Debt | 18.29B |
| Net Cash | -15.19B |
| Net Cash Per Share | -3.79 |
| Equity (Book Value) | 17.18B |
| Book Value Per Share | 4.40 |
| Working Capital | -3.98B |
Cash Flow
In the last 12 months, operating cash flow was 8.33 billion and capital expenditures -1.43 billion, giving a free cash flow of 6.90 billion.
| Operating Cash Flow | 8.33B |
| Capital Expenditures | -1.43B |
| Depreciation & Amortization | 1.13B |
| Net Borrowing | 775.00M |
| Free Cash Flow | 6.90B |
| FCF Per Share | 1.72 |
Margins
Gross margin is 73.49%, with operating and profit margins of 29.17% and 14.52%.
| Gross Margin | 73.49% |
| Operating Margin | 29.17% |
| Pretax Margin | 17.78% |
| Profit Margin | 14.52% |
| EBITDA Margin | 32.58% |
| EBIT Margin | 29.17% |
| FCF Margin | 20.78% |
Dividends & Yields
This stock pays an annual dividend of 0.72, which amounts to a dividend yield of 3.73%.
| Dividend Per Share | 0.72 |
| Dividend Yield | 3.73% |
| Dividend Growth (YoY) | 7.94% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 57.70% |
| Buyback Yield | 1.36% |
| Shareholder Yield | 5.09% |
| Earnings Yield | 6.23% |
| FCF Yield | 8.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for GSK plc is 2,142.05, which is 10.90% higher than the current price. The consensus rating is "Hold".
| Price Target | 2,142.05 |
| Price Target Difference | 10.90% |
| Analyst Consensus | Hold |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 4.05% |
| EPS Growth Forecast (3Y) | 6.00% |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
| Last Split Date | Jul 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.2 |
| Piotroski F-Score | 7 |